MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Teniposide

CAS No. : 29767-20-2

MCE 站：Teniposide

产品活性：Teniposide 是一种足叶草毒素衍生物，是拓扑异构酶 II (topoisomerase II) 的抑制剂，同时为一种化疗剂。

研究领域：Cell Cycle/DNA Damage

作用靶点：Topoisomerase

In Vitro: Teniposide is a topoisomerase II inhibitor. Teniposide (VM-26, 0.15-45 mg/L) inhibits the proliferation of Tca8113 cells in a dose-dependent manner, with an IC₅₀ of 0.35 mg/L. Teniposide (5 mg/L) induces apoptosis of Tca8113 cells. Teniposide (5.0 mg/L) causes cell arrested at G2/M phase in Tca8113 cells. Teniposide is active on primary cultured glioma cells from patients, when the level of miR-181b is high in the cells, with an IC₅₀ of 1.3?±?0.34 μg/mL. Cells treated with teniposide with low MDM2 have decreased viability compared with control cells, and the IC₅₀ decreases from 5.86?±?0.36 μg/mL to 2.90?±?0.35 μg/mL upon MDM2 suppression. Teniposide also inhibits the viability of glioma cell with high level of miR-181b, through mediation of MDM2.

In Vivo: Teniposide (0.5 mg/kg, i.p.) significantly increases micronucleated polychromatic erythrocyte (MNPCE) frequencies, which is directly related to bone marrow toxicity as significant suppression of bone marrow is noted. Teniposide (24 mg/kg, i.p.) markedly decreases the frequencies of BrdU-labelled sperm. Teniposide (12, 24 mg/kg, i.p.) also dramatically induces disomic sperm in the germ cell of male mice.

相关产品：Natural Product Like Compound Library  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Blood Cancer Compound Library  |  Doxorubicin hydrochloride  |  Etoposide  |  Irinotecan  |  SN-38  |  Camptothecin  |  Topotecan Hydrochloride  |  Epirubicin hydrochloride  |  Daunorubicin hydrochloride  |  Exatecan mesylate  |  Suramin sodium salt  |  Berberine chloride  |  Mitoxantrone  |  Betulinic acid  |  EIDD-1931  |  Idarubicin hydrochloride  |  Aldoxorubicin  |  Banoxantrone dihydrochloride  |  β-Lapachone  |  Hycanthone  |  Pirarubicin  |  Bisantrene  |  Aclacinomycin A hydrochloride  |  Amsacrine  |  Daun02

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。